Immunic Therapeutics (IMUX): Revenue Growth QoQ

Graphic logo of Immunic, Inc. (IMUX)

Quarterly revenue dynamics for Immunic, Inc. (IMUX) correlate with expectations following vidoflumimus calcium tests and the prospects of a Big Pharma acquisition. The development of unique tablets to combat multiple sclerosis aims to achieve long-term remission. The technology stack is further enhanced by AI-driven bioscreening automation. The value of 0.00 reflects the baseline metric level, capturing the company's current financial status.

IMUX immunic-therapeutics.com Quarterly Sales Growth (07/04/2022 - 11/20/2026)

Financial and market metric breakdowns for Immunic Inc (IMUX)

- stock price and consensus target price:
Fundamental company analysis:Immunic Inc (IMUX)
Mass-produced product of Immunic Therapeutics

Quarterly revenue growth measures the percentage change in sales volume of the current period compared to the same quarter of the previous year, revealing business scaling rates and the risk of stagnation. For Immunic, Inc. under the leadership of Daniel Vittorius, the quarterly revenue growth trajectory reflects the commercial efficiency of developing multiple sclerosis drugs, confirming the fundamental resilience and quality of the company's assets.

Competitor analysis

argenx BVBA - Quarterly Revenue Growth|BNTX: Revenue Growth QoQ|ABVX: Quarterly Revenue Growth|Sales Growth QoQ ADMA|Revenue Growth QoQ protagonist-inc.com|Quarterly Sales Growth Immunovant, Inc. (IMVT)|Quarterly Revenue Growth KNSA|GRFS: Revenue Dynamics QoQ|Adaptive Biotechnologies - Quarterly Sales Growth|CLDX: Sales Growth QoQ|Aurinia Corp - Quarterly Revenue Growth|Quarterly Revenue Growth Rate BioCryst Corp|VERA: Quarterly Revenue Growth|dianthustx.com (DNTH) - Quarterly Revenue Growth|PHVS (Pharvaris NV) - Quarterly Revenue Growth|ABCL: Quarterly Revenue Increase|Revenue Growth QoQ Tourmaline Bio, Inc. (TRML)|PGEN (Intrexon) - Quarterly Revenue Increase|Quarterly Revenue Growth PHAR (Pharming Corp)|nektar.com (NKTR) - Quarterly Revenue Growth Rate|UPB - Revenue Growth QoQ|Quarterly Revenue Increase ZBIO (Zenas Biopharma)|IMNM: Quarterly Revenue Growth|Quarterly Revenue Growth Rate Gossamer Bio, Inc. (GOSS)|Revenue Growth QoQ KalVista Pharmaceuticals|Septerna Inc (SEPN) - Quarterly Sales Growth Rate|Quarterly Revenue Growth PVLA|SVRA (Savara) - Quarterly Revenue Increase|Rigel Pharma - Quarterly Sales Growth|Quarterly Sales Growth Rate AnaptysBio Corp (ANAB)|ATXS: Quarterly Sales Growth|Quarterly Revenue Increase ENGN (enGene Holdings Inc.)|RAPT Therapeutics Inc. (RAPT) - Revenue Growth QoQ|Aerovate Therapeutics Inc (JBIO) - Quarterly Revenue Growth|ACRS (Aclaris Therapeutics, Inc) - Quarterly Revenue Growth|Kyverna (KYTX) - Quarterly Sales Growth Rate|Quarterly Revenue Growth TLSA|Quarterly Sales Growth Cabaletta Bio, Inc. CABA|Ventyx Biosciences - Quarterly Sales Growth|THTX: Sales Growth QoQ|AVTX - Revenue Growth QoQ|ELDN: Revenue Growth QoQ|Agenus Inc. (AGEN) - Revenue Growth QoQ|Quarterly Sales Growth Climb Bio Inc|ZURA (Zura Bio Ltd) - Quarterly Revenue Growth|Quarterly Revenue Growth aTyr Pharma Inc|Quarterly Revenue Growth ADAG|Quarterly Sales Growth Rate ImageneBio|Quarterly Revenue Growth STTK (Shattuck Labs Inc)|Quarterly Revenue Growth Equillium, Inc. EQ|CNTB - Revenue Growth QoQ|Revenue Dynamics QoQ ATRA|IFRX (InflaRx) - Quarterly Sales Growth|X4 Pharma (XFOR) - Quarterly Revenue Growth|ACET (Adicet) - Quarterly Revenue Growth|Quarterly Sales Growth celularity.com (CELU)|Revenue Growth QoQ INmune Bio Inc (INMB)|Quarterly Sales Growth Rate Barinthus Biotherapeutics PLC|Revenue Growth QoQ Kezar Life Sciences Inc KZR|Quarterly Revenue Increase SABS|AKTX - Revenue Growth QoQ|Quarterly Revenue Increase ENLV (enlivex.com)|QTTB: Quarterly Revenue Growth|Sales Growth QoQ GOVX|Quarterly Sales Growth EDSA|Sales Growth QoQ IBIO (iBio Corp)|Revenue Growth QoQ Carisma Therapeutics Inc (CARM)|Quarterly Sales Growth Rate xtlbio.com|Bolt Biotherapeutics Inc. - Quarterly Sales Growth|HCW Biologics Inc (HCWB) - Quarterly Revenue Growth Rate|Aptevo - Quarterly Revenue Growth|AIM ImmunoTech (AIM) - Quarterly Sales Growth|Aditxt Corp (ADTX) - Revenue Growth QoQ|Sales Growth QoQ GRI|Quarterly Sales Growth XRTX|Quarterly Revenue Growth Rate Vyome Holdings Inc. HIND|Quarterly Revenue Growth REVB|Quarterly Sales Growth Rate Indaptus Corp|BiondVax Pharmaceuticals - Quarterly Sales Growth|CalciMedica Corp (CALI) - Quarterly Revenue Growth Rate|Affimed - Quarterly Revenue Growth|Quarterly Sales Growth Rate allakos.com ALLK|HOOKIPA Pharma (HOOK) - Revenue Growth QoQ|IGMS (IGM Biosciences Inc.) - Revenue Growth QoQ|ITOS (iTeos Therapeutics) - Quarterly Revenue Growth|Sales Growth QoQ OCEA (Ocean Biomedical)|Revenue Growth QoQ TC Biopharm (TCBP)|THRD (Third Harmonic Bio Inc.) - Quarterly Revenue Increase